Froedtert to test promising antiviral drug remdesivir on coronavirus patients

Froedert Hospital
Froedtert & the Medical College of Wisconsin said Wednesday it will begin administering remdesivir – an experimental COVID-19 drug that has shown some promise at fighting the coronavirus – to some of its critically ill…

Want to Read More?

Paid BizTimes subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In

Or click here to purchase a paywall bypass link for this article.

Get our email updates

Lauren Anderson
Lauren Anderson covers health care, nonprofits, education and insurance for BizTimes. Lauren previously reported on education for the Waukesha Freeman. She graduated from the University of Wisconsin-Madison, where she studied journalism, history and African studies. In her free time, Lauren enjoys spending time with family and friends and seeing live music wherever she can.

No posts to display